melatonin has been researched along with Carcinoma, Oat Cell in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lissoni, P | 2 |
| Paolorossi, F | 1 |
| Ardizzoia, A | 1 |
| Barni, S | 1 |
| Chilelli, M | 1 |
| Mancuso, M | 1 |
| Tancini, G | 1 |
| Conti, A | 2 |
| Maestroni, GJ | 1 |
| Ghielmini, M | 1 |
| Pagani, O | 1 |
| de Jong, J | 1 |
| Pampallona, S | 1 |
| Maestroni, G | 1 |
| Sessa, C | 1 |
| Cavalli, F | 1 |
| Viviani, S | 1 |
| Bidoli, P | 1 |
| Spinazzé, S | 1 |
| Rovelli, F | 1 |
2 trials available for melatonin and Carcinoma, Oat Cell
| Article | Year |
|---|---|
A randomized study of chemotherapy with cisplatin plus etoposide versus chemoendocrine therapy with cisplatin, etoposide and the pineal hormone melatonin as a first-line treatment of advanced non-small cell lung cancer patients in a poor clinical state.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cel | 1997 |
Double-blind randomized study on the myeloprotective effect of melatonin in combination with carboplatin and etoposide in advanced lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Carboplatin; Carc | 1999 |
1 other study available for melatonin and Carcinoma, Oat Cell
| Article | Year |
|---|---|
Normalization of the light/dark rhythm of melatonin after prolonged subcutaneous administration of interleukin-2 in advanced small cell lung cancer patients.
Topics: Carcinoma, Small Cell; Circadian Rhythm; Female; Humans; Injections, Subcutaneous; Interleukin-2; Li | 1992 |